Movano

Movano, Inc. is a health-focused technology company. The firm uses non-invasive technology to enable individuals and their healthcare partners to measure and manage their health conditions. It offers solutions through the app, the cloud, the wearable, and the sensor. The company was founded by Michael Leabman in January 2018 and is headquartered in Pleasanton, CA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Movano Health reports revenue growth but faces operating loss in Q1 2024

Movano Health's Q1 2024 performance showed revenue from Evie Ring shipments but an operating loss, mitigated by a $24 million private placement. The company aims to optimize operations, secure FDA clearance, and expand partnerships to drive growth and profitability.

Movano Health advances FDA-cleared products, eyes clinical trials for growth

Movano Health's Q2 2024 earnings call highlighted progress, challenges, and opportunities in the health monitoring technology sector. With a focus on product development, marketing strategies, and capital management, Movano aims to drive growth and innovation in the market.

Movano (MOVE) excels in Q3 with Evie Ring success and growth prospects

Movano's Q3 performance reflects strong sales, operational improvements, and a strategic focus on product development and partnerships. While facing challenges in a competitive market and regulatory compliance, the company is well-positioned to capitalize on growth opportunities through innovation and market expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

PLEASANTON, Calif. , Aug. 15, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced the development of a beta testing program with Stanford Health Applied Sports Science Department.

Movano Announces Beta Program with Stanford University to Advance the Development of Comprehensive Health Data Monitoring for its Wearable Ring Solution

Former Google FitBit and Liteboxer talent join Movano as it prepares for commercialization of the Movano Ring PLEASANTON, Calif. , Aug. 11, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the expansion of its go-to-market leadership team with two strategic hires: Daniel Amara is joining as Vice President of User Experience (UX) and User Interface (UI) and Jim Chambers as Vice President of Digital Marketing & Growth.

Movano Expands Go-To-Market Team with Vice President of UX and UI and Vice President of Digital Marketing and Growth

Vital health metric demonstrates wearable's potential to properly track heart health and detect possible illnesses PLEASANTON, Calif. , Aug. 9, 2022 /PRNewswire/ -- Movano Inc.  (NASDAQ: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces today the successful completion of a study with the University of California San Francisco (UCSF) to assess the accuracy of the Movano Ring's blood oxygen saturation (SpO2) and heart rate data.

Movano Ring Exceeds Accuracy Targets for SpO2 and Heart Rate Monitoring in Initial Hypoxia Study; Company Eyes FDA Submission

PLEASANTON, Calif. , Aug. 9, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report second quarter 2022 financial and operating results on Monday, August 15, 2022.

Movano to Report Second Quarter 2022 Financial Results on Monday, August 15, 2022

Movano Inc. (NASDAQ:MOVE ) Q1 2022 Earnings Conference Call May 12, 2022 5:00 PM ET Company Participants John Mastrototaro - CEO J. Cogan - CFO Michael Leabman - CTO Conference Call Participants Michael Diana - Maxim Group Mark Argento - Lake Street Operator J.

Movano Inc. (MOVE) CEO John Mastrototaro on Q1 2022 Results - Earnings Call Transcript

The Company was granted a new U.S. patent for the sensor's architecture that will enable accurate and cost-effective health monitoring in future medical devices PLEASANTON, Calif. , May 12, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announces it has successfully validated the functionality of its proprietary and patented system-on-a-chip (SoC).

Movano Successfully Completes Functional Testing of Smallest Ever Custom mmWave Sensor Designed for Non-Invasive Glucose and Cuffless Blood Pressure Monitoring

Conference call begins at 2:00 p.m. Pacific time today PLEASANTON, Calif.

Movano Inc. Provides Business Update and Reports First Quarter 2022 Financial Results

American Heart Association consortium advances development of evidence-based health tech solutions PLEASANTON, Calif. , May 3, 2022 /PRNewswire/ -- Movano , a healthcare solutions company at the intersection of medtech and consumer devices, has joined the American Heart Association Center for Health Technology & Innovation's (the Center) Innovators' Network.

Movano Joins Innovators' Network at American Heart Association Center for Health Technology & Innovation

PLEASANTON, Calif. , April 22, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, today announced that it will report first quarter 2022 financial and operating results on Thursday, May 12, 2022.

Movano to Report First Quarter 2022 Financial Results on Thursday, May 12, 2022

Veteran health media executive joins the board of directors as Movano prepares for growth and commercialization PLEASANTON, Calif. , April 18, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announced the expansion of its board of directors with the addition of Nan Kirsten Forte, a thought leader within the healthcare media industry with a track record of success in marketing, partnerships, go-to-market execution, and mergers and acquisitions.

Movano Welcomes Nan Kirsten Forte, a Pioneer and Innovator in Digital Health, as Its Newest Board Member

The Company also provided a broader update on recent hiring initiatives PLEASANTON, Calif. , April 18, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices, announced the expansion of its senior leadership team with the strategic hire of Chief Marketing Officer (CMO), Tyla Bucher.

Movano Hires Chief Marketing Officer to Implement Its Multi-Channel Marketing Strategy for the Movano Ring and Future Medical Devices

Symbolic Logic, Inc.

Neuronetics Inc

The ISM services PMI rose to 58.3 in March from 56.5 in the previous month. Investors, meanwhile, focused on some notable insider trades.

Executives Buy Around $1M Of 4 Penny Stocks

Movano Inc. (MOVE) CEO John Mastrototaro on Q4 2021 Results - Earnings Call Transcript

Movano Inc. Provides Business Update and Reports Fourth Quarter 2021 Financial Results

PLEASANTON, Calif., March 10, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, today announced that it will report fourth quarter 2021 financial and operating results on Thursday, March 24, 2022.

Movano to Report Fourth Quarter 2021 Financial Results on Thursday, March 24, 2022

PLEASANTON, Calif., Feb. 17, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, today announced the completion of an Institutional Review Board (IRB)-approved glucose pilot study, which was conducted on 10 participants with type 1 diabetes of varying gender, age, ethnicity and weight in conjunction with an independent FDA-compliant clinical lab.

Movano Completes its Second Glucose Pilot Study

PLEASANTON, Calif.  , Feb. 15, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced the expansion if its senior leadership team with two new strategic hires - Stacy Salvi as Vice President of Strategy and Michael Soule as Vice President of Business Development.

Movano Announces Two Key Hires to Further Its Go-To-Market Strategy for the Movano Ring and Future Medical Devices

PLEASANTON, Calif., Feb. 7, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced that it will be participating in the virtual BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference on Tuesday, February 15 – Thursday, February 17, 2022.

Movano to Participate in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

PLEASANTON, Calif., Jan. 27, 2022 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced it has been awarded three new U.S. patents, increasing its total number of issued U.S. patents to six.

Movano Strengthens Intellectual Property for its Non-Invasive Sensor Technology with Three New U.S. Patents

PLEASANTON, Calif., Jan. 10, 2022 /PRNewswire/ --  Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announced that it will be participating in the 24th Annual Needham Virtual Growth Conference on Wednesday, January 12, 2022.

Movano to Participate in 24th Annual Needham Virtual Growth Conference

PLEASANTON, Calif. , Jan. 3, 2022 /PRNewswire/ -- Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, today announced the completion of an Institutional Review Board (IRB)-approved blood pressure clinical study, which was conducted on 110 consented participants at the Movano Clinical Lab over a six week period in the fourth quarter of 2021.

Movano Completes Blood Pressure Study with 110 Participants

My first in-person experience with a fitness ring was back at CES 2017. Four years later, one wonders if they might be having a moment at next week's show — in-person or no.

Movano targets an H2 2022 launch for its fitness ring

PLEASANTON, Calif., Dec. 27, 2021 /PRNewswire/ -- Movano Inc. (Nasdaq: MOVE), a health technology company designing devices that inspire and empower you to live a healthier, happier life, announces its debut device, the Movano Ring, to be showcased at CES 2022.

Movano Unveils Smart Ring Designed for Women Seeking More Approachable Health Insights

Movano Inc. (MOVE) CEO John Mastrototaro on Q3 2021 Results - Earnings Call Transcript

PLEASANTON, Calif., Nov. 11, 2021 /PRNewswire/ -- Today, Movano Inc. (NASDAQ:MOVE), a health technology company designing devices that empower individuals to optimize their health in order to help prevent and better manage chronic diseases, reported financial results for the three months ending September 30, 2021 and provided a business update.

News for Movano Stock (MOVE)